Literature DB >> 16083986

Prolonged Q-T(c) interval in mild portal hypertensive cirrhosis.

Henriette Ytting1, Jens H Henriksen, Stefan Fuglsang, Flemming Bendtsen, Søren Møller.   

Abstract

BACKGROUND/AIMS: The Q-T(c) interval is prolonged in a substantial fraction of patients with cirrhosis, thus indicating delayed repolarisation. However, no information is available in mild portal hypertensive patients. We therefore determined the Q-T(c) interval in cirrhotic patients with hepatic venous pressure gradient (HVPG) < 12 mmHg.
METHODS: Forty-four patients with cirrhosis and HVPG < 12 mmHg underwent a haemodynamic study. They were compared with 36 cirrhotic patients with clinically significant portal hypertension (HVPG> or = 12 mmHg) and controls without liver disease.
RESULTS: The fraction with prolonged Q-T(c) interval (> 0.440 s(1/2)) was similar in the two cirrhotic groups (49 vs 50%, ns) and significantly above that of the controls (5%, P < 0.005). Q-T(c) was normal in patients with normal HVPG. Likewise, mean Q-T(c) was 0.449 and 0.447 s(1/2) in the two cirrhotic groups (ns), values which are significantly above that of the controls (0.410 s(1/2), P < 0.01). In the mild portal hypertensive group, the Q-T(c) interval was inversely related to indicators of liver function, such as indocyanine green clearance (r = -0.34, P < 0.02).
CONCLUSIONS: Delayed repolarisation of the myocardium already occurs in a substantial fraction of patients with cirrhosis with only a mild increase in portal pressure. The prolonged Q-T(c) interval may be related to liver dysfunction and to the presence of portal hypertension.

Entities:  

Mesh:

Year:  2005        PMID: 16083986     DOI: 10.1016/j.jhep.2005.04.015

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

Review 1.  Arrhythmia risk in liver cirrhosis.

Authors:  Ioana Mozos
Journal:  World J Hepatol       Date:  2015-04-08

Review 2.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

3.  Diagnosis and Management of Cirrhotic Cardiomyopathy.

Authors:  Harpreet Kaur; Madhumita Premkumar
Journal:  J Clin Exp Hepatol       Date:  2021-08-21

4.  Establishment and validation of ALPH-Q score to predict mortality risk in patients with acute-on-chronic hepatitis B liver failure: a prospective cohort study.

Authors:  Sheng-Jie Wu; Hua-Dong Yan; Zai-Xing Zheng; Ke-Qing Shi; Fa-Ling Wu; Yao-Yao Xie; Yu-Chen Fan; Bo-Zhi Ye; Wei-Jian Huang; Yong-Ping Chen; Ming-Hua Zheng
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

5.  Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C.

Authors:  Yuki Tahata; Ryotaro Sakamori; Ayako Urabe; Naoki Morishita; Ryoko Yamada; Takayuki Yakushijin; Naoki Hiramatsu; Yoshinori Doi; Akira Kaneko; Hideki Hagiwara; Yukinori Yamada; Taizo Hijioka; Masami Inada; Shinji Tamura; Yasuharu Imai; Kunimaro Furuta; Takahiro Kodama; Hayato Hikita; Tomohide Tatsumi; Tetsuo Takehara
Journal:  Hepatol Commun       Date:  2018-08-06

Review 6.  Cirrhotic Cardiomyopathy: The Interplay Between Liver and Cardiac Muscle. How Does the Cardiovascular System React When the Liver is Diseased?

Authors:  Spyros P Dourakis; Eleni Geladari; Charalampia Geladari; Natalia Vallianou
Journal:  Curr Cardiol Rev       Date:  2021

7.  Prevalence of prolonged QT interval in patients with HCV-related chronic liver disease.

Authors:  Ahmed E Gaafar; Amr Abd El-Aal; Mohamed Alboraie; Housam M Hassan; Adel ElTahan; Yasser AbdelRahman; Mohamed-Naguib Wifi; Dalia Omran; Shimaa Afify Mansour; Waleed M Hassan; Magdy Ismail; Mohamed El Kassas
Journal:  Egypt Heart J       Date:  2019-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.